Kevin
Private Equity Investor chez Baleon Capital
Profil
Kevin Scoby is a Principal at Baleon Capital.
He oversees all aspects of the firm's investment process including deal sourcing, due diligence and portfolio management.
Prior to joining Baleon Capital in 2023, Kevin was Assistant Vice President of Portfolio Management at Paragon Biosciences after starting his career as a private equity professional at The Tokarz Group Advisers and Public Pension Capital (Principal) where he was involved in all transaction stages including sourcing, valuations, modeling, and due diligence.
Kevin received his B.S.
degree in Economics (Finance Concentration) from The Wharton School, University of Pennsylvania
Postes actifs de Kevin
| Sociétés | Poste | Début |
|---|---|---|
Baleon Capital
 Baleon Capital Investment ManagersFinance leon capital (Baleon capital) is a venture capital founded in 2020. The firm is headquartered in Miami, Florida. | Private Equity Investor | 07/09/2023 |
Anciens postes connus de Kevin
| Sociétés | Poste | Fin |
|---|---|---|
Paragon Biosciences LLC
 Paragon Biosciences LLC Miscellaneous Commercial ServicesCommercial Services Paragon Biosciences LLC is a life science innovator that creates, invests in, and builds life science companies in biopharmaceuticals, cell and gene therapy, and synthetic biology utilizing artificial intelligence. Paragon Biosciences is based in Chicago, IL, and has subsidiaries in the United States. The private company's current portfolio includes Castle Creek Biosciences, Circ Biosciences, Emalex Biosciences, Evozyne, Harmony Biosciences Holdings, Qlarity Imaging, Skyline Biosciences, and a consistent flow of incubating companies created and supported by the Paragon Innovation Capital™ model. The company's mission is to solve complex human and societal challenges by creating and supporting focused, visionary companies that accelerate the development of novel therapies and life science breakthroughs. The company was founded by Jeffrey S. Aronin, who has been the CEO since incorporation. | Directeur/Membre du Conseil | 02/08/2023 |
PPC Enterprises, LLC
 PPC Enterprises, LLC Investment ManagersFinance PPC Enterprises LLC (PPC Enterprises) is a private equity firm founded in 2012 by Perry Golkin and Michael Tokarz. The firm is headquartered in New York. | Private Equity Investor | 31/03/2019 |
The Tokarz Group Advisers LLC
 The Tokarz Group Advisers LLC Investment ManagersFinance The Tokarz Group Advisers LLC (Tokarz Group Advisers) is a private equity firm founded in 2006 by Michael Theodore Tokarz. The firm is headquartered in Purchase, New York. | Private Equity Investor | 01/03/2019 |
Formation de Kevin
| University of Pennsylvania | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
The Tokarz Group Advisers LLC
The Tokarz Group Advisers LLC Investment ManagersFinance The Tokarz Group Advisers LLC (Tokarz Group Advisers) is a private equity firm founded in 2006 by Michael Theodore Tokarz. The firm is headquartered in Purchase, New York. | Finance |
PPC Enterprises, LLC
PPC Enterprises, LLC Investment ManagersFinance PPC Enterprises LLC (PPC Enterprises) is a private equity firm founded in 2012 by Perry Golkin and Michael Tokarz. The firm is headquartered in New York. | Finance |
Baleon Capital
Baleon Capital Investment ManagersFinance leon capital (Baleon capital) is a venture capital founded in 2020. The firm is headquartered in Miami, Florida. | Finance |
Paragon Biosciences LLC
Paragon Biosciences LLC Miscellaneous Commercial ServicesCommercial Services Paragon Biosciences LLC is a life science innovator that creates, invests in, and builds life science companies in biopharmaceuticals, cell and gene therapy, and synthetic biology utilizing artificial intelligence. Paragon Biosciences is based in Chicago, IL, and has subsidiaries in the United States. The private company's current portfolio includes Castle Creek Biosciences, Circ Biosciences, Emalex Biosciences, Evozyne, Harmony Biosciences Holdings, Qlarity Imaging, Skyline Biosciences, and a consistent flow of incubating companies created and supported by the Paragon Innovation Capital™ model. The company's mission is to solve complex human and societal challenges by creating and supporting focused, visionary companies that accelerate the development of novel therapies and life science breakthroughs. The company was founded by Jeffrey S. Aronin, who has been the CEO since incorporation. | Commercial Services |
